- Home
- INNV vs IRWD Comparison
INNV vs IRWD Comparison
Compare INNV & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INNV
- IRWD
- Stock Information
- Founded
- INNV 2007
- IRWD 1998
- Country
- INNV United States
- IRWD United States
- Employees
- INNV N/A
- IRWD N/A
- Industry
- INNV Medical/Nursing Services
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- INNV Health Care
- IRWD Health Care
- Exchange
- INNV Nasdaq
- IRWD Nasdaq
- Market Cap
- INNV 839.0M
- IRWD 716.9M
- IPO Year
- INNV 2021
- IRWD 2010
- Fundamental
- Price
- INNV $6.03
- IRWD $4.51
- Analyst Decision
- INNV Hold
- IRWD Buy
- Analyst Count
- INNV 2
- IRWD 5
- Target Price
- INNV $6.50
- IRWD $14.00
- AVG Volume (30 Days)
- INNV 44.6K
- IRWD 1.8M
- Earning Date
- INNV 09-10-2024
- IRWD 11-07-2024
- Dividend Yield
- INNV N/A
- IRWD N/A
- EPS Growth
- INNV N/A
- IRWD N/A
- EPS
- INNV N/A
- IRWD 0.06
- Revenue
- INNV $763,855,000.00
- IRWD $400,565,000.00
- Revenue This Year
- INNV $13.47
- IRWD N/A
- Revenue Next Year
- INNV $12.78
- IRWD $3.43
- P/E Ratio
- INNV N/A
- IRWD $81.54
- Revenue Growth
- INNV 11.01
- IRWD N/A
- 52 Week Low
- INNV $3.52
- IRWD $3.79
- 52 Week High
- INNV $7.20
- IRWD $15.70
- Technical
- Relative Strength Index (RSI)
- INNV 48.80
- IRWD 43.12
- Support Level
- INNV $5.83
- IRWD $4.35
- Resistance Level
- INNV $6.20
- IRWD $4.80
- Average True Range (ATR)
- INNV 0.25
- IRWD 0.29
- MACD
- INNV -0.05
- IRWD 0.04
- Stochastic Oscillator
- INNV 44.87
- IRWD 47.78
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.